Drug Profile
Salbutamol metered-dose inhalation - AstraZeneca
Alternative Names: Albuterol sulfate metered dose inhalation- Pearl Therapeutics; AS MDI; PT 007Latest Information Update: 03 Mar 2022
Price :
$50
*
At a glance
- Originator Pearl Therapeutics
- Developer AstraZeneca
- Class Antiasthmatics; Antibronchitics; Bronchodilators; Ethanolamines; Phenethylamines; Small molecules; Tocolytics
- Mechanism of Action Beta 2 adrenergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 03 Mar 2022 Discontinued - Phase-II for Asthma (In adolescents, In children, In adults) in USA (Inhalation)
- 03 Mar 2022 Discontinued - Phase-II for Asthma in USA (Inhalation)
- 17 May 2019 Efficacy and adverse event data from a phase II trial in Asthma presented at the 115th International Conference of the American Thoracic Society (ATS-2019)